EasyCheck-Prostate

Easycheck Prostate: An Annual Blood Test to Detect Prostate Cancer

EasyCheck is an advanced non-invasive blood test that provides evidence of an underlying malignancy using a safe, simple, and quick blood draw. EasyCheck-Prostate is a test to screen for the presence of prostate cancer in healthy males (above age 45 yrs) showing no symptoms of it. This test can play a vital role in the early detection of prostate cancer & help in improving the survival rates in patients through early detection.

EasyCheck is designed to detect Circulating Tumor Cells (CTCs), which are cancer cells that escape from the tumor and enter the bloodstream. EasyCheck enriches these CTCs from the blood sample.

Panels covered

This test checks the following malignancies: 

This test can play a vital role in the early detection of prostate cancer & help in improving the survival rates in patients through early detection.

Who should get tested?

EasyCheck is intended to be performed annually as a screening test, in individuals aged 30 years and above, who have no past history of cancer and are without any symptoms suggestive of cancer.

What does the report tell me?

The report will tell you if CTCs were detected (indicating a higher risk of the presence of carcinoma) or CTCs were not detected (indicating a lower risk of the presence of carcinoma) in the submitted sample. When Circulating Tumor Cells are detected, the results can indicate the location of the tumor in the body, allowing your healthcare practitioner to advise your next steps.

How to read the report?

For Positive report: Individuals with these findings are advised to consult with their physician for appropriate guidance and additional standard of care workup as may be advised.

For Negative report: EasyCheck test may be repeated annually and the individual is advised to consult a physician if further guidance is required.

Please Note: This test is performed on blood samples from asymptomatic individuals for early detection of Prostate Adenocarcinoma only. After this screening test, further decisions on patient care and treatment must be based on the independent medical judgment of the treating physicians taking into consideration all available and relevant information concerning the patient's condition, such as personal and family history, physician's examination as well as information from other pertinent diagnostic tests and medical imaging and histopathology.